interleukin 1 receptor type 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| inflammatory response | ||
| immune response | ||
| cell surface receptor signaling pathway | ||
| positive regulation of platelet-derived growth factor receptor signaling pathway | ||
| smooth muscle adaptation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| external side of plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protease binding | ||
| NAD+ nucleosidase activity |
|
|
| transmembrane signaling receptor activity | ||
| interleukin-1 receptor activity | ||
| interleukin-1 receptor activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060645 | chronic recurrent multifocal osteomyelitis | |
| DOID:418 | systemic scleroderma | |
| DOID:9744 | type 1 diabetes mellitus |
| HPO ID | HPO Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0001945 | Fever |
| HP:0002653 | Bone pain |
| HP:0002754 | Osteomyelitis |
| HP:0003565 | Elevated erythrocyte sedimentation rate |
| HP:0100847 | Palmoplantar pustulosis |
| Disease ID | Disease Name |
|---|---|
| OMIM:259680 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026